Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
We summarize typical holdings and how index funds achieve broad market exposure with a defined set of constituents.
15,010 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Avantis U.S. Large Cap Value ETF (AVLV) has outpaced peers with a profitability-driven screen, posting a 24.5% gain o...
A single ETF quietly powered a decade of returns, turning $10,000 into close to $100,000. This article breaks down ho...
Schwab U.S. Dividend Equity ETF SCHD remains a cornerstone for income investors as of mid-2026, combining a low fee w...
When healthcare stocks rally, two ETFs often surface as popular bets: Vanguard Health Care (VHT) and Invesco Pharmace...
When a prominent fund makes a sizable stake reduction, it often signals more than profit-taking. This article breaks ...
Per Stirling Capital Management increased its stake in the First Trust Smith Opportunistic Fixed Income ETF (FIXD) by...
Want the best semiconductor with $1,000 exposure? This guide breaks down the smartest ETF picks, costs, and a practic...
As volatility stays elevated, a hedge against rising option premiums is gaining attention. The 8%-yield S&P 500 Premi...
The Roundhill Magnificent Seven ETF has delivered strong gains since its April 2023 start, but a growing concentratio...
Chasing alpha may feel exciting, but it often comes with higher costs and bigger risks. This guide explains why prayi...
XLV faces a pivotal year as it tracking to beat the S&P 500 in 2026. Analysts say two factors that will decide its fa...